FDA Orange Book · active-ingredient family
Xenon xe-133
Xenon xe-133 is approved in 7 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:XENON XE 133 · NDA 018327
7
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · gas, injectable, solution
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| XENON XE 133×2 | CURIUM | NDA 018327 | — | Mar 09, 1982 | |
| XENON XE 133×2 | GE HEALTHCARE | NDA 017256 | — | Approved Prior to Jan 1, 1982 | |
| XENON XE 133×3 | GE HEALTHCARE | NDA 017687 | — | Approved Prior to Jan 1, 1982 | |
| XENON XE 133×2 | GEN ELECTRIC | NDA 017550 | — | Approved Prior to Jan 1, 1982 | |
| XENON XE 133×2 | SHINE | NDA 017284 | — | Approved Prior to Jan 1, 1982 | |
| XENON XE 133 | LANTHEUS MEDCL | NDA 017283 | — | Approved Prior to Jan 1, 1982 | |
| XENEISOL | MALLINCKRODT | NDA 017262 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Xenon xe-133 — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
